Last updated: 2026-09-16 12:10:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Mesa Laboratories Inc. (MLAB) operates in the INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL sector and is listed on NASDAQ. The stock is currently priced at $130.50, with a market capitalisation of $679.79M and a P/E ratio of 148.23. Over the past 52 weeks, its price has ranged from $63.00 to $132.70. This page covers its latest market performance, valuation, price trends and company information.
$679.79M | |
$125.99 | |
$333.42 | |
$7.74 | |
$127.15 | |
5.00 | |
171.58K | |
148.23 | |
$132.70 | |
$63.00 | |
0.50% | |
-- |
Mesa Laboratories Inc. (MLAB) is trading at $130.50 in pre-market trading as of 2026-09-16 12:04:00, up 2.63% ($3.35) from the previous close of $127.15
Pre-market trading shows how investors are pricing MLAB before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Mesa Laboratories Inc. (MLAB) moved from $127.78 to $130.50, representing a gain of 2.13% ($2.72).
The stock traded between $119.07 and $130.50 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 139.70 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 96.8%
MLAB is currently trading at $130.50, placing it 96.8% of the way from its 52-week low of $63.00 to its 52-week high of $132.70. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
| Industry | INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL |
| Employees | 717 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Mesa Laboratories Inc. (MLAB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.